
The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression
Keywords: فاکتور رشد اپیدرمی; Glivec; Tyrosine kinase receptor; Growth factor; PDGF; Stem cell factorCML, chronic myelogenous leukemia; GIST, gastrointestinal stromal tumor; PDGF, platelet derived growth factor; 5-FU, 5-fluorouracil; EGF, epidermal growth factor; VEGF, vascular endoth